|
1B-LSD
1B-LSD (N1-butyryl-lysergic acid diethylamide) is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug. In tests on mice it was found to be an active psychedelic, though with only around 1/7 the potency of LSD itself. Legal status 1B-LSD is illegal in Singapore. Sweden's public health agency suggested classifying 1B-LSD as a hazardous substance, on June 24, 2019. See also * Lysergic acid diethylamide (LSD) * 1cP-LSD * 1P-LSD * 1V-LSD * ALD-52 * 1cP-AL-LAD * AL-LAD * ETH-LAD * 1P-ETH-LAD * PRO-LAD * LSM-775 * LSZ * O-Acetylpsilocin 4-Acetoxy-''N'',''N''-dimethyltryptamine (4-AcO-DMT or 4-acetoxy-DMT), also known as ''O''-acetylpsilocin or psilacetin, is a psychedelic drug of the tryptamine family related to psilocybin and psilocin. It is a synthetic derivative of psiloci ... (4-AcO-DMT) References External links 1B-LSD - Isomer Design1B-LSD - PsychonautWikiThe Small & Handy 1-Bu-LSD Thread - BluelightWhat is 1B-LSD? ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
1cP-LSD
1cP-LSD (''N''1-(cyclopropylmethanoyl)-lysergic acid diethylamide) is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug. It was first synthesized as a legal-LSD alternative by Lizard Labs, a Netherlands based research chemical laboratory. In tests on mice it was found to be an active psychedelic with similar potency to 1P-LSD. Legal status Public Health Agency of Sweden, Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on 18 December 2019 and later classified it as such on 22 April 2021. See also * Lysergic acid diethylamide (LSD) * 1B-LSD * 1DD-LSD * 1P-LSD * 1V-LSD * ALD-52 * 1cP-AL-LAD * AL-LAD * ETH-LAD * 1P-ETH-LAD * PRO-LAD * LSM-775 * Lysergic acid 2,4-dimethylazetidide, LSZ * O-Acetylpsilocin (4-AcO-DMT) References 5-HT2A agonists Designer drugs Prodrugs Psychedelic lysergamides Serotonin receptor agonists {{hallucinogen-stub ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Lysergic Acid 2,4-dimethylazetidide
Lysergic acid 2,4-dimethylazetidide, also known as LSZ, LA-SS-Az, or LA-Azetidide, is an analog of LSD developed by the team led by David E. Nichols at Purdue University. It was developed as a rigid analog of LSD with the diethylamide group constrained into an azetidine ring in order to map the binding site at the 5-HT2A receptor. There are three possible stereoisomers around the azetidine ring, with the (''S'',''S'')-(+) isomer being the most active, slightly more potent than LSD itself in drug discrimination tests using trained rats. There have been several unconfirmed reports of lysergic acid 2,4-dimethylazetidide being synthesized in illicit laboratories and distributed on blotter paper or in liquid solution under names such as "diazedine" and " λ". Dosage and effects The dosage of LSZ in humans is said to be 100 to 300μg orally, which is higher than the listed dosage of LSD (60–200μg). According to David E. Nichols, LSZ is about equipotent with LSD in humans. ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
ALD-52
ALD-52, also known as 1-acetyl-LSD (1A-LSD), is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It has been reported to produce similar psychoactive effects as LSD, but its pharmacological effects on humans are poorly understood. The drug is assumed to act as a prodrug to LSD in humans, and this has been substantiated ''in vitro''. ALD-52 was initially synthesized in 1957 by Albert Hofmann. The purported first confirmed detection of the substance on the illicit market occurred in April 2016. Use and effects In Entry 26 of his compendium '' TiHKAL'', which discussed LSD, chemist Alexander Shulgin touched briefly on the subject of ALD-52. His comments there are vague, second-hand accounts saying doses in the 50–175 μg range have resulted in various conclusions. One account found that there was less visual distortion than with LSD and it seemed to produce less anxiety and tenseness and that it was somewhat less potent. One subj ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
1P-LSD
1P-LSD, also known as 1-propanoyl-lysergic acid diethylamide (1-propionyl-LSD), is a psychedelic drug of the lysergamide class that is a derivative and functional analogue of LSD and a homologue of ALD-52. It originated in 2015 when it appeared a designer drug sold online. It was first synthesized as a legal-LSD alternative by Lizard Labs, a Netherlands based research chemical laboratory. It modifies the LSD molecule by adding a propionyl group to the nitrogen atom of LSD's indole group. Pharmacology Like ALD-52, 1P-LSD is believed to act as a prodrug for LSD via hydrolysis of the propionyl group. When 1P-LSD is incubated in human serum, administered intravenously to rats, or administered either orally or intravenously to human subjects, high levels of LSD and relatively low levels of 1P-LSD are quickly detected, demonstrating that 1P-LSD is rapidly hydrolyzed into LSD ''in vivo'' following ingestion. Indeed, following intravenous administration in humans 1P-LSD is detectable ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
1V-LSD
1V-LSD (1-valeryl-D-lysergic acid diethylamide), sometimes nicknamed Valerie, is a psychotropic substance and a research chemical with psychedelic effects. 1V-LSD is an artificial derivative of natural lysergic acid, which occurs in ergot alkaloids, as well as being an analogue of LSD. 1V-LSD has been sold online until an amendment to the German NpSG was enforced in 2022 which controls 1P-LSD and now 1cP-LSD, 1V-LSD and several other lysergamides. Pharmacology As demonstrated with other N-acylated derivatives of LSD, 1V-LSD is believed to serve as a prodrug for LSD but may also act as a weak partial agonist at the 5-HT2A receptor. Animal studies A Head-twitch response assay in mice found that 1V-LSD has a similar potency to 1P-LSD and 1cP-LSD, with behavioral effects also closely resembling these structural analogs. Interactions Chemistry 1V-LSD is the condensation product of valeric acid (pentanoic acid) and LSD, where the valeroyl group is substituted on the N ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
AL-LAD
AL-LAD, also known as 6-allyl-6-nor-LSD, is a psychedelic drug of the substituted lysergamide, lysergamide family related to lysergic acid diethylamide (LSD). It was first described by 1976. Subsequently, the drug was described by Alexander Shulgin in his 1997 book ''TiHKAL'' (''Tryptamines i Have Known And Loved''). Later, AL-LAD was encountered as a novel designer drug, designer recreational drug by 2015. Use and effects AL-LAD is taken oral administration, orally at similar doses as LSD, but has a slightly shorter duration of action, duration of 6 to 8hours instead of 8 to 12hours. While AL-LAD has subtly different effects than LSD, and appears to be slightly shorter-lasting, their potency (pharmacology), potencies are similar; an active dose of AL-LAD is reported to be between 50 and 150 micrograms. Interactions Pharmacology Pharmacodynamics AL-LAD was about 3.5-fold more potency (pharmacology), potent than LSD in substituting for LSD in drug discrimination tests in rod ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Prodrugs
A prodrug is a pharmacologically inactive Pharmaceutical drug, medication or compound that, after Drug administration, intake, is Drug metabolism, metabolized (i.e., converted within the body) into a pharmacologically active drug. Instead of administering a drug directly, a corresponding prodrug can be used to improve how the drug is absorbed, distributed, metabolized, and excreted (ADME). Prodrugs are often designed to improve bioavailability when a drug itself is poorly absorbed from the gastrointestinal tract. A prodrug may be used to improve how selectively the drug interacts with cells or processes that are not its intended target. This reduces adverse or unintended effects of a drug, especially important in treatments like chemotherapy, which can have severe unintended and undesirable side effects. History Many herbal extracts historically used in medicine contain glycosides (sugar derivatives) of the active agent, which are hydrolyzed in the intestines to release the a ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Designer Drugs
A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests. Designer drugs include psychoactive substances that have been designated by the European Union, Australia, and New Zealand, as new psychoactive substances (NPS) as well as analogs of performance-enhancing drugs such as designer steroids. Some of these designer drugs were originally synthesized by academic or industrial researchers in an effort to discover more potent derivatives with fewer side effects and shorter duration (and possibly also because it is easier to apply for patents for new molecules) and were later co-opted for recreational use. Other designer drugs were prepared for the first time in clandestine laboratories. Because the efficacy and safety of these substances have not been thoroughly evaluated in animal and human tr ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
5-HT2A Agonists
Serotonin (), also known as 5-hydroxytryptamine (5-HT), is a monoamine neurotransmitter with a wide range of functions in both the central nervous system (CNS) and also peripheral tissues. It is involved in mood, cognition, reward, learning, memory, and physiological processes such as vomiting and vasoconstriction. In the CNS, serotonin regulates mood, appetite, and sleep. Most of the body's serotonin—about 90%—is synthesized in the gastrointestinal tract by enterochromaffin cells, where it regulates intestinal movements. It is also produced in smaller amounts in the brainstem's raphe nuclei, the skin's Merkel cells, pulmonary neuroendocrine cells, and taste receptor cells of the tongue. Once secreted, serotonin is taken up by platelets in the blood, which release it during clotting to promote vasoconstriction and platelet aggregation. Around 8% of the body's serotonin is stored in platelets, and 1–2% is found in the CNS. Serotonin acts as both a vasoconstrictor and v ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
O-Acetylpsilocin
4-Acetoxy-''N'',''N''-dimethyltryptamine (4-AcO-DMT or 4-acetoxy-DMT), also known as ''O''-acetylpsilocin or psilacetin, is a psychedelic drug of the tryptamine family related to psilocybin and psilocin. It is a synthetic derivative of psilocin (4-HO-DMT) in which the hydroxyl group has been acetylated, and is the analogue of psilocybin (4-PO-DMT) in which the phosphate ester has been replaced with an acetate ester. The drug is a prodrug of psilocin and is orally active similarly to psilocybin. As a prodrug of psilocin, 4-AcO-DMT acts as a non-selective serotonin receptor agonist, including of the serotonin 5-HT2A receptor. The hallucinogenic effects of psilocin are thought to be mediated by activation of this receptor, although other receptors also contribute to its effects. 4-AcO-DMT's effects are reported to be similar to those of psilocybin and psilocybin mushrooms. However, it has been said to have reduced side effects such as nausea and body load that can be cause ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
LSM-775
LSM-775, also known as ''N''-morpholinyllysergamide or as lysergic acid morpholide, is a chemical derivative, derivative of ergine (lysergamide). It is less potent than lysergic acid diethylamide (LSD) but is reported to have some LSD-like effects at doses ranging from 75 to 700 micrograms and a shorter duration of action, duration. LSM-775 may only produce weak or threshold serotonergic psychedelic, psychedelic effects in humans. The drug is a potency (pharmacology), potent full agonist of the serotonin 5-HT1A receptor, 5-HT1A receptor and a potent partial agonist of the serotonin 5-HT2A receptor, 5-HT2A, 5-HT2B receptor, 5-HT2B, and 5-HT2C receptor, 5-HT2C receptors. It does not produce the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. However, LSM-775 can robustly increase head twitches if it is coadministered with the serotonin 5-HT1A receptor receptor antagonist, antagonist WAY-100635. These findings indicate that serotonin 5-HT1A receptor acti ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
PRO-LAD
PRO-LAD, also known as 6-propyl-6-nor-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). Use and effects PRO-LAD was described by Alexander Shulgin in his book ''TiHKAL''. It is a psychedelic similar to LSD, and has around the same potency as LSD itself, with an active dose reported at between 100 and 200μg. Interactions Pharmacology Pharmacodynamics PRO-LAD is slightly more potent in substituting for LSD in rodent drug discrimination tests than LSD itself. Society and culture Legal status Switzerland PRO-LAD is illegal in Switzerland as of December 2015. United Kingdom On June 10, 2014, the United Kingdom Advisory Council on the Misuse of Drugs (ACMD) recommended that PRO-LAD be specifically named in the UK Misuse of Drugs Act as a class A drug despite not identifying it as ever having been sold or any harm associated with its use. The UK Home office accepted this advice and announced a ban of the substance to be enacted on 6 ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
